PDCD1LG2 and prostate carcinoma: In another study, Zhao and colleagues recently reported an assessment of over 9000 prostatectomy specimens, linking programmed death-ligand 2 (PD-L2) to poorer biochemical recurrence-free survival and prostate cancer-specific survival.